enow.com Web Search

Search results

1. Results from the WOW.Com Content Network

2. Paricalcitol - Wikipedia

   en.wikipedia.org/wiki/Paricalcitol

   Paricalcitol (chemically it is 19-nor-1,25-(OH) 2-vitamin D 2.Marketed by Abbott Laboratories under the trade name Zemplar) is a drug used for the prevention and treatment of secondary hyperparathyroidism (excessive secretion of parathyroid hormone) associated with chronic kidney failure.

3. Secondary hyperparathyroidism - Wikipedia

   en.wikipedia.org/wiki/Secondary_hyperparathyroidism

   It can help treat SHPT by increasing Vitamin D levels and lowering parathyroid hormone or PTH. It is not indicated for people with stage 5 CKD or on dialysis. [citation needed] In the treatment of secondary hyperparathyroidism due to chronic kidney disease on dialysis calcimimetics do not appear to affect the risk of early death. [5]

4. Hyperparathyroidism - Wikipedia

   en.wikipedia.org/wiki/Hyperparathyroidism

   Secondary hyperparathyroidism typically occurs due to vitamin D deficiency, chronic kidney disease, or other causes of low blood calcium. [1] The diagnosis of primary hyperparathyroidism is made by finding elevated calcium and PTH in the blood. [2] Primary hyperparathyroidism may only be cured by removing the adenoma or overactive parathyroid ...

5. Calcimimetic - Wikipedia

   en.wikipedia.org/wiki/Calcimimetic

   A calcimimetic is a pharmaceutical drug that mimics the action of calcium on tissues, by allosteric activation of the calcium-sensing receptor that is expressed in various human organ tissues. Calcimimetics are used to treat secondary hyperparathyroidism (SHPT). [1] [2]

6. Cinacalcet - Wikipedia

   en.wikipedia.org/wiki/Cinacalcet

   Cinacalcet, sold under the brand name Sensipar among others, is a medication used to treat primary hyperparathyroidism, tertiary hyperparathyroidism and parathyroid carcinoma. [ 4 ] [ 6 ] [ 5 ] Cinacalcet acts as a calcimimetic (i.e., it mimics the action of calcium on tissues ) by allosteric activation of the calcium-sensing receptor that is ...

7. Primary hyperparathyroidism - Wikipedia

   en.wikipedia.org/wiki/Primary_hyperparathyroidism

   The most common cause of primary hyperparathyroidism is a sporadic, single parathyroid adenoma [5] resulting from a clonal mutation (~97%). Less common are parathyroid hyperplasia [6] (~2.5%), parathyroid carcinoma (malignant tumor), and adenomas in more than one gland (together ~0.5%).Primary hyperparathyroidism is also a feature of several familial endocrine disorders: Multiple endocrine ...